With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces the appointments of Elizabeth Holt as Chief Business Officer (CBO) and Dr Mark ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behavior or ...

In early UK corporate news, Phoenix Group lifted its 2026 profit outlook after meeting a cash generation goal sooner than expected. AstraZeneca announced a USD1 billion acquisition. Elsewhere, there ...

The global rib fracture repair systems market is on track for substantial expansion, projected to grow from USD 420.3 million in 2022 to an estimated USD 699.5 million by 2032. This represents a ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Pharmaceutical company GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya ...

A global pharmaceutical company, having recently acquired a mid-cap biotech firm, sought to evaluate the market value of a ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Malignant Infantile Osteopetrosis (MIOP), also known as autosomal recessive osteopetrosis, is a rare genetic disorder that ...

While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data ...